---
title: FDA Issues Guidance on Verification Systems
description: FDA recently issued a Guidance regarding verification systems requirements as they relate to the Drug Supply Chain Security Act.
image: https://info.consortiex.com/hubfs/fdalogo.png
---

[![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png "ConsortiEX")](https://www.consortiex.com)

- [Home](https://consortiex.com/)
- Solutions 
    - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/)
    - [Assure-Trak® | Health System](https://consortiex.com/health-system/)
    - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/)
    - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/)
- [ConsortiEX Blog](https://info.consortiex.com/blog)
- More 
    - [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
    - [Meet the Team](https://www.consortiex.com/meet-our-team/)
    - [Resources](https://info.consortiex.com/resources)
    - [DSCSA Resources](https://consortiex.com/dscsa-resources/)
- Contact 
    - [Current Customer Support](https://consortiex.com/support/)
    - [Request a Demo](https://consortiex.com/contact-us/)

- [Home](https://consortiex.com/)
- Solutions 
    - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/)
    - [Assure-Trak® | Health System](https://consortiex.com/health-system/)
    - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/)
    - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/)
- [ConsortiEX Blog](https://info.consortiex.com/blog)
- More 
    - [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
    - [Meet the Team](https://www.consortiex.com/meet-our-team/)
    - [Resources](https://info.consortiex.com/resources)
    - [DSCSA Resources](https://consortiex.com/dscsa-resources/)
- Contact 
    - [Current Customer Support](https://consortiex.com/support/)
    - [Request a Demo](https://consortiex.com/contact-us/)

December 13, 2018

# FDA Issues Guidance on Verification Systems

The FDA recently issued a draft guidance regarding verification\* systems in accordance with the Drug Supply Chain Security Act ([DSCSA](https://www.consortiex.com/dscsa-compliance-as-a-service/)).

The purpose of the guidance was to assist the industry in understanding what requirements need to be met in a variety of situations. The verification requirements apply to manufacturers, wholesale distributors, dispensers and repackagers.

The [FDA](https://www.fda.gov/) insists that all trading partners in the supply chain have systems in place that allow them to comply with regulation regarding suspect or illegitimate product. The systems must be able to consistently determine the legitimacy of a product in a timely manner, to prioritize patient safety.

Trading partners should put an emphasis on tracking products that may fall into one of the defined categories of suspect product (counterfeit, diverted, stolen, intentionally adulterated, part of a fraudulent transaction, or unfit for distribution).

The FDA reserves the right request verification, that a product is legitimate, from a trading partner if they have determined that they may be in possession or control of an illegitimate product.  If the product is determined to be illegitimate, the partner must identify and quarantine all related products in its possession or control.

Due to the risks that are posed by illegitimate products entering the supply chain, the FDA urges all trading partners to do their due diligence to identify these products as early as possible.

The FDA outlines specific minimum requirements for each verification system. The systems outlined in the guidance are:

 

- Determine the Legitimacy of a Product
- Suspect Product Quarantine and Investigation
- Cleared Product Notification Regarding Suspect Products
- Illegitimate Product Quarantine and Disposition
- Illegitimate/High Risk of Illegitimate Product Notifications
- Responding to Requests for Verification
- Processing Saleable Returns

 

As of today, all trading partners in the pharmaceutical supply chain must have systems in place to meet these guidelines and respond to request, within hours of a request.

Click [here](https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM624205.pdf) to read the full FDA Guidance on Verification Systems.

 

*The FDA notes that a draft guidance does not hold legal authority.*

*\*Verification as defined by the FDA: Determining whether the product identifier affixed to, or imprinted upon, a package, or homogenous case, corresponds to the standardized numerical identifier, or lot number, and expiration dates assigned to the product by the manufacturer, as applicable, in accordance with section 582*

[ConsortiEX ASHP Midyear Recap, Prioritizing Patient Safety](https://info.consortiex.com/blog/consortiex-ashp18-midyear-recap) [In Recent Guidance, FDA aims for Patient Safety at 503B Facilities](https://info.consortiex.com/blog/fda-guidance-503b)

### Related Posts

## [ConsortiEX Soars to Support Dream Flights, and US Veterans](https://info.consortiex.com/blog/consortiex-supports-dream-flights)

## [ConsortiEX and LedgerDomain Announce Strategic Partnership](https://info.consortiex.com/blog/consortiex-and-ledgerdomain-announce-strategic-partnership)

## [ConsortiEX Customer Spotlight | Cape Cod Healthcare](https://info.consortiex.com/blog/consortiex-customer-spotlight-cape-cod-healthcare)

### Recent Posts

- [In Response to the FDA Announcement](https://info.consortiex.com/blog/in-response-to-the-fda)   
  October 11, 2024
- [ConsortiEX Soars to Support Dream Flights, and US Veterans](https://info.consortiex.com/blog/consortiex-supports-dream-flights)   
  August 6, 2024
- [ConsortiEX and LedgerDomain Announce Strategic Partnership](https://info.consortiex.com/blog/consortiex-and-ledgerdomain-announce-strategic-partnership)   
  March 13, 2024

### Topics

- [ConsortiEX (22)](https://info.consortiex.com/blog/tag/consortiex)
- [DSCSA (21)](https://info.consortiex.com/blog/tag/dscsa)
- [DQSA (18)](https://info.consortiex.com/blog/tag/dqsa)
- [FDA (18)](https://info.consortiex.com/blog/tag/fda)
- [Compounding (17)](https://info.consortiex.com/blog/tag/compounding)
- [batch compounding (16)](https://info.consortiex.com/blog/tag/batch-compounding)
- [drug quality and security act (16)](https://info.consortiex.com/blog/tag/drug-quality-and-security-act)
- [patient safety (16)](https://info.consortiex.com/blog/tag/patient-safety)
- [assure-trak (15)](https://info.consortiex.com/blog/tag/assure-trak)
- [Blog (14)](https://info.consortiex.com/blog/tag/blog)
- [Track and Trace (13)](https://info.consortiex.com/blog/tag/track-and-trace)
- [Drug Supply Chain Security Act (12)](https://info.consortiex.com/blog/tag/drug-supply-chain-security-act)
- [IV workflow software (12)](https://info.consortiex.com/blog/tag/iv-workflow-software)
- [Industry (12)](https://info.consortiex.com/blog/tag/industry)
- [Pharmacy IT software (11)](https://info.consortiex.com/blog/tag/pharmacy-it-software)
- [health care pharmacy (11)](https://info.consortiex.com/blog/tag/health-care-pharmacy)
- [iv workflow (11)](https://info.consortiex.com/blog/tag/iv-workflow)
- [503B (10)](https://info.consortiex.com/blog/tag/503b)
- [503A (9)](https://info.consortiex.com/blog/tag/503a)
- [compliance (9)](https://info.consortiex.com/blog/tag/compliance)
- [iv workflow management (9)](https://info.consortiex.com/blog/tag/iv-workflow-management)
- [Total Ingredient Life Cycle (8)](https://info.consortiex.com/blog/tag/total-ingredient-life-cycle)
- [enterprise resource planning (8)](https://info.consortiex.com/blog/tag/enterprise-resource-planning)
- [pedigree to patient (8)](https://info.consortiex.com/blog/tag/pedigree-to-patient)
- [pharmacy software (8)](https://info.consortiex.com/blog/tag/pharmacy-software)
- [traceability (8)](https://info.consortiex.com/blog/tag/traceability)
- [USP (7)](https://info.consortiex.com/blog/tag/usp)
- [anticipatory compounding (7)](https://info.consortiex.com/blog/tag/anticipatory-compounding)
- [assure-track (6)](https://info.consortiex.com/blog/tag/assure-track)
- [pharmaceutical compounding (6)](https://info.consortiex.com/blog/tag/pharmaceutical-compounding)
- [Spotlight (5)](https://info.consortiex.com/blog/tag/spotlight)
- [compounded sterile preparations (5)](https://info.consortiex.com/blog/tag/compounded-sterile-preparations)
- [compounded sterile productions (5)](https://info.consortiex.com/blog/tag/compounded-sterile-productions)
- [pharmacy (5)](https://info.consortiex.com/blog/tag/pharmacy)
- [pharmacy it (5)](https://info.consortiex.com/blog/tag/pharmacy-it)
- [quality assurance (5)](https://info.consortiex.com/blog/tag/quality-assurance)
- [DSCSA Compliance (4)](https://info.consortiex.com/blog/tag/dscsa-compliance)
- [EDI (4)](https://info.consortiex.com/blog/tag/edi)
- [News (4)](https://info.consortiex.com/blog/tag/news)
- [T3 Documentation (4)](https://info.consortiex.com/blog/tag/t3-documentation)
- [USP 797 (4)](https://info.consortiex.com/blog/tag/usp-797)
- [clean room (4)](https://info.consortiex.com/blog/tag/clean-room)
- [compounded IV bags (4)](https://info.consortiex.com/blog/tag/compounded-iv-bags)
- [compounded syringe (4)](https://info.consortiex.com/blog/tag/compounded-syringe)
- [drug serialization (4)](https://info.consortiex.com/blog/tag/drug-serialization)
- [order management (4)](https://info.consortiex.com/blog/tag/order-management)
- [sterile product compounding (4)](https://info.consortiex.com/blog/tag/sterile-product-compounding)
- [transaction history transaction information transa (4)](https://info.consortiex.com/blog/tag/transaction-history-transaction-information-transa)
- [DQSA - USP 797 (3)](https://info.consortiex.com/blog/tag/dqsa-usp-797)
- [DSCSA CaaS (3)](https://info.consortiex.com/blog/tag/dscsa-caas)
- [DSCSA Software (3)](https://info.consortiex.com/blog/tag/dscsa-software)
- [Drug Counterfeiting (3)](https://info.consortiex.com/blog/tag/drug-counterfeiting)
- [EPCIS (3)](https://info.consortiex.com/blog/tag/epcis)
- [Requirements (3)](https://info.consortiex.com/blog/tag/requirements)
- [drug borrow loan (3)](https://info.consortiex.com/blog/tag/drug-borrow-loan)
- [dscsa compliance as a service 3T (3)](https://info.consortiex.com/blog/tag/dscsa-compliance-as-a-service-3t)
- [exchange (3)](https://info.consortiex.com/blog/tag/exchange)
- [guidance (3)](https://info.consortiex.com/blog/tag/guidance)
- [illegitimate product (3)](https://info.consortiex.com/blog/tag/illegitimate-product)
- [pharmacy erp (3)](https://info.consortiex.com/blog/tag/pharmacy-erp)
- [suspect product (3)](https://info.consortiex.com/blog/tag/suspect-product)
- [3Ts (2)](https://info.consortiex.com/blog/tag/3ts)
- [ASHP (2)](https://info.consortiex.com/blog/tag/ashp)
- [COVID-19 (2)](https://info.consortiex.com/blog/tag/covid-19)
- [Compliance as a Service (2)](https://info.consortiex.com/blog/tag/compliance-as-a-service)
- [Compounding Pharmacy (2)](https://info.consortiex.com/blog/tag/compounding-pharmacy)
- [DSCSA service (2)](https://info.consortiex.com/blog/tag/dscsa-service)
- [DSCSA software and service (2)](https://info.consortiex.com/blog/tag/dscsa-software-and-service)
- [Data Entry (2)](https://info.consortiex.com/blog/tag/data-entry)
- [Drug supply chain transparency (2)](https://info.consortiex.com/blog/tag/drug-supply-chain-transparency)
- [Electronic Data Interchange (2)](https://info.consortiex.com/blog/tag/electronic-data-interchange)
- [Environmental monitoring (2)](https://info.consortiex.com/blog/tag/environmental-monitoring)
- [Manual T3 Conversion (2)](https://info.consortiex.com/blog/tag/manual-t3-conversion)
- [NDC tracking (2)](https://info.consortiex.com/blog/tag/ndc-tracking)
- [Passive auditing (2)](https://info.consortiex.com/blog/tag/passive-auditing)
- [Prescription tracking (2)](https://info.consortiex.com/blog/tag/prescription-tracking)
- [T3 (2)](https://info.consortiex.com/blog/tag/t3)
- [T3 Conversion (2)](https://info.consortiex.com/blog/tag/t3-conversion)
- [T3s (2)](https://info.consortiex.com/blog/tag/t3s)
- [compounded IV bag (2)](https://info.consortiex.com/blog/tag/compounded-iv-bag)
- [compounded syringes (2)](https://info.consortiex.com/blog/tag/compounded-syringes)
- [drug supply chain (2)](https://info.consortiex.com/blog/tag/drug-supply-chain)
- [drug transfers (2)](https://info.consortiex.com/blog/tag/drug-transfers)
- [dscsa deadline (2)](https://info.consortiex.com/blog/tag/dscsa-deadline)
- [fda guidance (2)](https://info.consortiex.com/blog/tag/fda-guidance)
- [patient specific compounding (2)](https://info.consortiex.com/blog/tag/patient-specific-compounding)
- [pharmacy serialization (2)](https://info.consortiex.com/blog/tag/pharmacy-serialization)
- [pharmacy supply chain (2)](https://info.consortiex.com/blog/tag/pharmacy-supply-chain)
- [product (2)](https://info.consortiex.com/blog/tag/product)
- [product identifier (2)](https://info.consortiex.com/blog/tag/product-identifier)
- [quarantine (2)](https://info.consortiex.com/blog/tag/quarantine)
- [regulation (2)](https://info.consortiex.com/blog/tag/regulation)
- [serialization (2)](https://info.consortiex.com/blog/tag/serialization)
- [sterile injectable compound (2)](https://info.consortiex.com/blog/tag/sterile-injectable-compound)
- [vaccine (2)](https://info.consortiex.com/blog/tag/vaccine)
- [503B. outsourcing facility (1)](https://info.consortiex.com/blog/tag/503b-outsourcing-facility)
- [Bar Code Medication Verification (1)](https://info.consortiex.com/blog/tag/bar-code-medication-verification)
- [Central Sterile Compounding (1)](https://info.consortiex.com/blog/tag/central-sterile-compounding)
- [Cleanroom (1)](https://info.consortiex.com/blog/tag/cleanroom)
- [Compounding Quality Act (1)](https://info.consortiex.com/blog/tag/compounding-quality-act)
- [ISMP (1)](https://info.consortiex.com/blog/tag/ismp)
- [Pharmacy Informatics (1)](https://info.consortiex.com/blog/tag/pharmacy-informatics)
- [Technology Assisted IV Workflow Software (1)](https://info.consortiex.com/blog/tag/technology-assisted-iv-workflow-software)
- [USP . USP 800 (1)](https://info.consortiex.com/blog/tag/usp-usp-800)
- [audit (1)](https://info.consortiex.com/blog/tag/audit)
- [barcode (1)](https://info.consortiex.com/blog/tag/barcode)
- [central-fill (1)](https://info.consortiex.com/blog/tag/central-fill)
- [community involvement (1)](https://info.consortiex.com/blog/tag/community-involvement)
- [compounding management system (1)](https://info.consortiex.com/blog/tag/compounding-management-system)
- [deadline (1)](https://info.consortiex.com/blog/tag/deadline)
- [draft guidance (1)](https://info.consortiex.com/blog/tag/draft-guidance)
- [drug loan borrow (1)](https://info.consortiex.com/blog/tag/drug-loan-borrow)
- [drug waste (1)](https://info.consortiex.com/blog/tag/drug-waste)
- [dynamic patient specific (1)](https://info.consortiex.com/blog/tag/dynamic-patient-specific)
- [grandfathered (1)](https://info.consortiex.com/blog/tag/grandfathered)
- [grandfathered product (1)](https://info.consortiex.com/blog/tag/grandfathered-product)
- [software (1)](https://info.consortiex.com/blog/tag/software)
- [specialty compounding (1)](https://info.consortiex.com/blog/tag/specialty-compounding)
- [verification systems (1)](https://info.consortiex.com/blog/tag/verification-systems)

See all

[![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)](http://acc-dev.consortiex.com/)

- <https://twitter.com/ConsortiEX>
- <https://www.linkedin.com/company/10680398/>

*733 N Van Buren St, Ste 501*  
*Milwaukee, WI 53202*

*Office: (414) 231-4575*   
*Support: (888) 434-1442*

*Email: info@consortiex.com*

- [Homepage](https://www.consortiex.com/)
- [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
- [Blog](https://info.consortiex.com/blog)
- [Contact Us](https://www.consortiex.com/contact-us/)
- [DSCSA Compliance](https://www.consortiex.com/dscsa-compliance/)
- [Health System](https://www.consortiex.com/health-system/)
- [Magnifier™ Analytics](https://consortiex.com/consortiex-magnifier-analytics/)
- [Outsourcing Facility 503B](https://www.consortiex.com/outsourcing-facility-503b/)
- [Resources](https://info.consortiex.com/resources)

 2025 | ConsortiEX Inc. | All Rights Reserved